ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.


Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
01 2021
Historique:
entrez: 13 3 2021
pubmed: 14 3 2021
medline: 24 4 2021
Statut: ppublish

Résumé

A European consensus conference on endometrial carcinoma was held in 2014 to produce multidisciplinary evidence-based guidelines on selected questions. Given the large body of literature on the management of endometrial carcinoma published since 2014, the European Society of Gynaecological Oncology (ESGO), the European SocieTy for Radiotherapy & Oncology (ESTRO) and the European Society of Pathology (ESP) jointly decided to update these evidence-based guidelines and to cover new topics in order to improve the quality of care for women with endometrial carcinoma across Europe and worldwide. ESGO/ESTRO/ESP nominated an international multidisciplinary development group consisting of practicing clinicians and researchers who have demonstrated leadership and expertise in the care and research of endometrial carcinoma (27 experts across Europe). To ensure that the guidelines are evidence-based, the literature published since 2014, identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the development group. The guidelines are thus based on the best available evidence and expert agreement. Prior to publication, the guidelines were reviewed by 191 independent international practitioners in cancer care delivery and patient representatives. The guidelines comprehensively cover endometrial carcinoma staging, definition of prognostic risk groups integrating molecular markers, pre- and intra-operative work-up, fertility preservation, management for early, advanced, metastatic, and recurrent disease and palliative treatment. Principles of radiotherapy and pathological evaluation are also defined.

Identifiants

pubmed: 33712263
pii: S0167-8140(20)31188-9
doi: 10.1016/j.radonc.2020.11.018
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

327-353

Informations de copyright

Copyright © 2021 International Gynecologic Cancer Society and European Society of Gynecological Oncology [Published by BMJ]; Springer Verlag GmbH Berlin Heidelberg, part of Springer Nature. Published by Elsevier B.V. All rights reserved.

Auteurs

Nicole Concin (N)

Department of Gynecology and Obstetrics, Innsbruck Medical University, Austria; Evangelische Kliniken Essen-Mitte, Germany. Electronic address: nicole.concin@i-med.ac.at.

Xavier Matias-Guiu (X)

Department of Pathology, Hospital Universitari Arnau de Vilanova, University of Lleida, CIBERONC, Irblleida, Spain; Department of Pathology, Hospital Universitari de Bellvitge, University of Barcelona, Idibell, Spain.

Ignace Vergote (I)

Department of Gynecology and Obstetrics, Gynecologic Oncology, Leuven Cancer Institute, Catholic University Leuven, Belgium.

David Cibula (D)

Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University, General University Hospital in Prague, Czech Republic.

Mansoor Raza Mirza (MR)

Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Denmark.

Simone Marnitz (S)

Department of Radiation Oncology, Medical Faculty of the University of Cologne, Germany.

Jonathan Ledermann (J)

UCL Cancer Institute, University College, London, UK.

Tjalling Bosse (T)

Department of Pathology, Leids Universitair Medisch Centrum, Leiden, Netherlands.

Cyrus Chargari (C)

Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France.

Anna Fagotti (A)

Division of Gynecologic Oncology, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy.

Christina Fotopoulou (C)

Department of Gynaecologic Oncology, Imperial College London Faculty of Medicine, UK.

Antonio Gonzalez Martin (AG)

Department of Medical Oncology, Clinica Universidad de Navarra, Madrid, Spain.

Sigurd Lax (S)

Department of Pathology, Hospital Graz II, Austria; School of Medicine, Johannes Kepler University Linz, Austria.

Domenica Lorusso (D)

Division of Gynecologic Oncology, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy.

Christian Marth (C)

Department of Obstetrics and Gynecology, Innsbruck Medical University, Austria.

Philippe Morice (P)

Department of Surgery, Institut Gustave Roussy, Villejuif, France.

Remi A Nout (RA)

Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, Netherlands.

Dearbhaile O'Donnell (D)

Department of Medical Oncology, St James Hospital, Dublin, Ireland.

Denis Querleu (D)

Division of Gynecologic Oncology, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy; Department of Obstetrics and Gynecologic Oncology, University Hospital, Strasbourg, France.

Maria Rosaria Raspollini (MR)

Histopathology and Molecular Diagnostics, Azienda Ospedaliero Universitaria Careggi, Florence, Italy.

Jalid Sehouli (J)

Department of Gynecology with Center for Oncological Surgery, Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Germany.

Alina Sturdza (A)

Department of Radiation Oncology, Comprehensive Cancer Center, Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna, Austria.

Alexandra Taylor (A)

Department of Gynaecology, Royal Marsden Hospital, London, UK.

Anneke Westermann (A)

Department of Medical Oncology, Amsterdam University Medical Centres, Noord-Holland, Netherlands.

Pauline Wimberger (P)

Department of Gynecology and Obstetrics, TU Dresden Medizinische Fakultat Carl Gustav Carus, Germany.

Nicoletta Colombo (N)

Gynecologic Oncology Program, European Institute of Oncology, IRCCS, Milan and University of Milan-Bicocca, Italy.

François Planchamp (F)

Clinical Research Unit, Institut Bergonie, Bordeaux, France.

Carien L Creutzberg (CL)

Department of Radiation Oncology, Leiden University Medical Center, Leiden Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH